Clinical utility of serum thyroglobulin measurement

Current Opinion in Endocrinology and Diabetes

Volumn 9, Issue 5, 2002, Pages 401-406

  Spencer, Carole A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RADIOACTIVE IODINE; THYROGLOBULIN; THYROGLOBULIN ANTIBODY; THYROTROPIN;

ACCURACY; ALGORITHM; ASSAY; HUMAN; IMMUNOASSAY; NONHUMAN; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; REVIEW; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA;

EID: 0038001577     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200210000-00007     Document Type: Review

References (26)

1. Spencer CA, Wang CC: Thyroglobulin measurement: Techniques, clinical benefits and pitfalls. Endocrinol Metab Clin N Amer 1995, 24:841-863.
2. Spencer CA: Thyroglobulin. In The Thyroid: A Fundamental and Clinical Text. Edited by Braverman LE and Utiger RD, Philadelphia: Lippincott Williams & Wilkins; 2000.
3. Torrens JI, Burch HB: Serum thyroglobulin measurement. Utility in clinical practice. Endocrinol Metab Clin N Amer 2001,30:429-467.
4. Demers LM, Spencer CA: 2002. Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease. National Academy of Clinical Biochemistry web site. Available at http://www.nacb.org/Thyroid_LMPG.stm. Accessed July 8, 2002.
5. Spencer CA, Takeuchi M, Kazarosyan M: Current Status and Performance Goals for Serum Thyroglobulin Assays. Clin Chem 1996,42:164-173.
6. Cohen JH, Ingbar SH, Braverman LE: Thyrotoxicosis due to ingestion, of excess thyroid hormone. Endocrine Rev 1989,10:113-124.
7. Mitchell ML, Hermos RJ: Measurement of thyroglobulin in newborn screening specimens from normal and hypothyroid infants. Clin Endocrinol 1995,42:523-527.
8. Knudsen N, Bulow I, Jorgensen T, et al.: Serum Tg - a sensitive marker of thyroid abnormalities and iodine deficiency in epidemiological studies. J Clin Endocrinol Metab 2001,86:3599-3603.
9. Gardner DF, Rothman J, Utiger RD: Serum thyroglobu[in in normal subjects and patients with hyperthyroidism due to Graves' disease: effects of T3, iodide, 1311 and antithyroid drugs. Clin Endocrinol 1979,11:585-594.
10. Ericson UB, Tegler L, Lennquist S, et al.: Serum thyroglobulin in differentiated thyroid carcinoma. Acta Chir Scand 1984,150:367-375.
11. Fatemi S, Nicoloff J, LoPresti J, et al.: Clinical utility of a pre-op serum thyroglobulin (Tg) measurement in patients with differentiated papillary thyroid cancer (PTC). American Thyroid Association, 69th Annual Meeting, 1999. West Palm Beach, FL Abstract.
12. Hocevar M, Auersperg M, Stanovnik L: The dynamics of serum thyroglobulin elimination from the body after thyroid surgery. 1997,23:208-210.
13. Ronga G, Filesi M, Ventroni G, et al.: Value of the first serum thyroglobulin level after thyroidectomy for the diagnosis of metastases from differentiated thyroid carcinoma. Eur J Nucl Med 1999,26:1448-1452.
14. Feldt-Rasmussen U, Schlumberger M: European interlaboratory comparison of serum thyroglobulin measurement. J Endocrinol Invest 1988,11:175-181.
15. Haugen BR, Pacini F, Reiners C, et al.: A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. J Clin Endocrinol Metab 1999,84:3877-3885.
16. Haugen BR, Ridgway EC, McLaughlin BA, et al.: Clinical comparison of whole-body radioiodine scan and serum thyroglobulin after stimulation with recombinant human thyrotropin. Thyroid 2002,12:37-43.
17. Schlumberger M, Charbord P, Fragu P, et al.: Circulating thyrotropin and thyroid hormones in patients with metastases of differentiated thyroid carcinoma: relation to serum thyrotropin levels. J Clin Endocrinol Metab 1980,51:513-519.
18. Spencer CA, LoPresti JS, Fatemi S, et al.:. Detection of residual and recurrent differentiated thyroid carcinoma by serum Thyroglobulin measurement. Thyroid 1999,9:435-441.
19. Schlumberger MJ: Papillary and Follicular Thyroid Carcinoma. N Engl J Med 1998;338:297-306.
20. Feldt-Rasmussen U, Profilis C, Colinet E, et al.: Human thyroglobulin reference material (CRM 457) 2nd part: Physicochemical characterization and certification. Ann Biol Clin 1996,54:343-348.
21. Spencer CA, Wang C, Fatemi S, et al.: Serum Thyroglobulin Autoantibodies: Prevalence, influence on serum thyroglobulin measurement and prognostic significance in patients with differentiated thyroid carcinoma. J Clin Endocrinol Metab 1998,83:1121-1127.
22. Pacini F, Mariotti S, Formica N, et al.: Thyroid autoantibodies in thyroid cancer: Incidence and relation with tumor outcome. Acta Endocrinol 1988,119:373-380.
23. Rubello D, Casara D, Girelli ME, et al.: Clinical meaning of circulating antithyroglobulin antibodies in differentiated thyroid cancer: a prospective study. J Nucl Med 1992,33:1478-1480.
24. Levinson SS: The nature of heterophilic antibodies and their role in immunoassay interference. J Clin Immunoassay 1992;15:108-115.
25. Mariotti S, Barbesino G, Caturegli P, et al.: Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? J Clin Endocrinol Metab 1995,80:468-472.
26. Massart C, Maugendre D: Importance of the detection method for thyroglobulin antibodies for te validity of thyroglobulin measurements in sera from patients with Graves' disease. Clin Chem 2002,48:102-107.